Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD...

Bradley Patt, CEO of GMI, said, "We are extremely pleased that Dr. O'Connor and his team at Mayo have chosen GMI to bring their important technology to market.

EarthTimes, 12/15/09

Tags: Business Relations, Gamma Medica-Ideas, Inc, molecular breast imaging